SCYNEXIS, Inc. to Participate in Two Upcoming Investor Conferences

Wednesday, September 4, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

JERSEY CITY, N.J., Sept. 4, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present in the following investor conferences:

  • The H.C. Wainwright Global Investment Conference at the Lotte
    New York Palace Hotel in New York City on Monday, September 9, 2019 at 2:10 p.m. ET.
  • The Ladenburg Thalmann Healthcare Conference at the Sofitel New York in New York City on Tuesday, September 24, 2019 at 1:30 p.m. ET.

Live webcasts of the presentations will be available on the Investors section of the Company's website: www.scynexis.com. Replays of the presentations will be available approximately two hours after each event and will be available for two weeks following each presentation.

About SCYNEXISSCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, having discovered and developed more than 30 innovative medicines over a broad range of therapeutic areas. SCYNEXIS's lead product candidate, ibrexafungerp (formerly known as SCY-078), is a novel IV/oral antifungal agent in Phase 3 clinical and preclinical development for the treatment of multiple serious and life-threatening invasive fungal infections caused by CandidaAspergillus and Pneumocystis species. For more information, visit www.scynexis.com.

CONTACT: 

Investor RelationsHeather SavelleArgot PartnersTel: 212-600-1902heather@argotpartners.com

Media RelationsGeorge E. MacDougallMacDougallTel: 781-235-3093george@macbiocom.com

Cision View original content:http://www.prnewswire.com/news-releases/scynexis-inc-to-participate-in-two-upcoming-investor-conferences-300911120.html

SOURCE SCYNEXIS, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store